论文部分内容阅读
紫衫醇作为卵巢癌第一线治疗药美国研究人员在美国临床肿瘤学协会第２９次会议上报道，在首次大规模临床试验中，Ｂｒｉｓｔｏｌ－ＭｙｅｒｓＳｑｕｉｂｂ公司的抗癌药－紫杉醇（ｐａｃｌｉｔａｘｅｌＴａｘｏｌ）对新近确诊的进行性卵巢癌患者的疗效，被证实优于标准化疗...
As the first line of treatment of ovarian cancer, US researchers at the 29th meeting of the American Society of Clinical Oncology reported that in the first large-scale clinical trial, Bristol-Myers Squibb’s anticancer drug paclitaxelTaxol recently The efficacy of diagnosed patients with ovarian cancer was confirmed to be superior to standard chemotherapy ...